Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 27.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 230,35 250 | 230,35 | 250 | 8,154878 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 230,35 275 | 230,35 | 275 | 18,970366 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 230,35 250 | 230,35 | 250 | 8,154878 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 230,35 300 | 230,35 | 300 | 29,785853 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 230,35 250 | 230,35 | 250 | 8,154878 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 230,35 260 | 230,35 | 260 | 12,481073 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 230,35 250 | 230,35 | 250 | 8,154878 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,35 332 | 230,35 | 332 | 43,629678 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,35 275 | 230,35 | 275 | 18,970366 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,35 275 | 230,35 | 275 | 18,970366 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 230,35 250 | 230,35 | 250 | 8,154878 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 230,35 275 | 230,35 | 275 | 18,970366 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 230,35 332 | 230,35 | 332 | 43,629678 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 230,35 332 | 230,35 | 332 | 43,629678 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 230,35 390 | 230,35 | 390 | 68,721609 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 230,35 436 | 230,35 | 436 | 88,622107 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 230,35 415 | 230,35 | 415 | 79,537097 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 230,35 390 | 230,35 | 390 | 68,721609 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 230,35 390 | 230,35 | 390 | 68,721609 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 230,35 415 | 230,35 | 415 | 79,537097 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 230,35 390 | 230,35 | 390 | 68,721609 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 230,35 360 | 230,35 | 360 | 55,743024 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 230,35 295 | 230,35 | 295 | 27,622756 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 230,35 295 | 230,35 | 295 | 27,622756 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 230,35 350 | 230,35 | 350 | 51,416829 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 230,35 352 | 230,35 | 352 | 52,282068 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 230,35 295 | 230,35 | 295 | 27,622756 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 230,35 270 | 230,35 | 270 | 16,807268 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 230,35 375 | 230,35 | 375 | 62,232317 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 230,35 315 | 230,35 | 315 | 36,275146 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 230,35 353 | 230,35 | 353 | 52,714687 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 230,35 500 | 230,35 | 500 | 116,309756 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,35 500 | 230,35 | 500 | 116,309756 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,35 290 | 230,35 | 290 | 25,459658 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,35 375 | 230,35 | 375 | 62,232317 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 230,35 391 | 230,35 | 391 | 69,154229 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 230,35 | 230,35 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 230,35 315 | 230,35 | 315 | 36,275146 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 230,35 400 | 230,35 | 400 | 73,047804 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 475 | 230,35 | 475 | 105,494268 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 230,35 600 | 230,35 | 600 | 159,571707 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 230,35 | 230,35 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 230,35 315 | 230,35 | 315 | 36,275146 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 230,35 315 | 230,35 | 315 | 36,275146 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 600 | 230,35 | 600 | 159,571707 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 230,35 391 | 230,35 | 391 | 69,154229 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 230,35 540 | 230,35 | 540 | 133,614536 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 230,35 290 | 230,35 | 290 | 25,459658 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 230,35 500 | 230,35 | 500 | 116,309756 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 230,35 500 | 230,35 | 500 | 116,309756 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,35 290 | 230,35 | 290 | 25,459658 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,35 340 | 230,35 | 340 | 47,090634 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,35 540 | 230,35 | 540 | 133,614536 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 230,35 315 | 230,35 | 315 | 36,275146 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 230,35 540 | 230,35 | 540 | 133,614536 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 230,35 600 | 230,35 | 600 | 159,571707 | DEUTSCHE BANK RESEARCH |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M